TSEM
TEVA

Amir Elstein

Known title: DirectorCIK: 0001721354

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Tower Semiconductor expands Semtech AI chip manufacturing agreement. Tower Semiconductor announced an expanded manufacturing agreement with Semtech to provide capacity for AI data centre connectivity chips across three regions. The move is highlighted as a potential boost for the company amid growing AI chip demand. Analysts have noted the development while semiconductor stocks have been rising after recent market weakness.

this person other insiders at TSEM

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Teva Receives FDA Approval for Weltruza, Announces R&D Day. Teva Pharmaceutical Industries secured FDA approval for Weltruza, a once‑monthly long‑acting injectable for schizophrenia. The approval follows the company’s announcement of an R&D day in New York City, where it will discuss its pipeline and future research plans. Barclays raised its price target to $47, citing the new product launch and potential growth in the schizophrenia market. These developments add fresh catalysts to Teva’s outlook.

Transaction History

TSEM▲ Buy$0
TEVA▲ Buy—
TEVA▲ Buy—
TEVA▲ Buy—
TEVA▲ Buy—
TEVA▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.